Meeting: Tau Ventures

Date: 2026-02-06 Attendees: Thomas Startz, Michael Yuan, Sam Bogrov (Tau Ventures) Type: Catch-up / market color + fundraise positioning feedback Duration: ~35 min

---

Summary

Casual, friendly call with Sam from Tau. Known from Wharton network. Sam is on the healthcare side while the partners are raising their next fund. Tau likely not the right fit for this round (they don't lead, do ~$500K checks, typically want revenue before investing). But extremely valuable as positioning feedback and market intel. Key takeaway: the blurb/positioning reads like "helping implement an LLM" which triggers the wrapper alarm — the business is much better than how it's being described. Sam suggested talking to Zen (Emily) and Tara (Flair) for additional perspectives.

---

Questions Asked

---

Concerns Raised

• Blurb triggers "wrapper" alarm — Sam was explicit: "from the blurb it's like, so they're building a wrapper on an LLM." He said the business makes sense when explained but the written positioning doesn't convey that. "You want to make sure you're getting the credit you deserve when you send around the blurb."

• No revenue yet — Sam noted Tau specifically wants "IRR coming through the door" before investing. This is a Tau-specific policy but reflects broader investor preference.

---

What Resonated

• FDE thesis broadly — Sam connected it to Palantir, to GC (Abhinav/Lipsa's work), to the broader "organizations need technical people embedded" trend
• Payer pressure narrative — Sam shared his own intel validating it (Cigna contact, Alafia portfolio, payer tech stack issues)
• Revenue model breakdown — The SaaS fee + implementation fee + maintenance/licensing fee structure was the clearest articulation yet. Sam said it made sense.

---

Our Commitments

• Send deck to Sam
• Fix the blurb — don't lead with LLM
• Reach out to Tara (Flair) and Zen/Emily for positioning feedback

Their Next Steps

• Sam will look at deck, think about who could be a fit for intros
• Tau unlikely to invest at this stage (don't lead, want revenue, $500K checks)
• May revisit at next stage

---

Investor Insights

Firm:

• Tau Ventures — healthcare side, Sam is one of three underlings. Partners raising next fund (limited bandwidth).
• Don't lead. Usually second/third largest check, ~$500K. Want a lead investor in place.
• Typically invest once revenue is flowing ("IRR coming through the door").
• Enterprise side of firm may have different lens.

Valuation intel (from Sam):

• Seed stage: assume 15-20% dilution. $2M raise → roughly $8-10M post-money.
• Earlier stage, ownership targets matter less. Math doesn't always work out to neat multiples.
• Firms that lead (Hippo, Flair) will have ownership targets. Smaller/non-lead funds may not.
• Can increase round size to help lead hit ownership target while reducing dilution percentage.

Market intel:

• Alafia — Tau portfolio, focused on fraud/miscoding on payer side
• AI doctors / regulatory shift — Utah allowing AI doctors. Not on most people's bingo cards. Driven by Oz, not Kennedy.
• Cigna contact told Sam: payer tech systems are "absolute trash," nothing communicates, everything manual. Biggest concern is integration requirements. Pilots die because of integration complexity.
• JPM conference — not worth it for most healthcare VCs, but everyone going to ViVe

Positioning feedback (CRITICAL):

• The blurb leads with LLM → triggers "wrapper" fear
• "Dumb investor first look" = "so they're building a wrapper on an LLM"
• Sam: "To be clear, there's a difference between the blurb and the actual business. My question is on the blurb side, not the business side."
• Michael's point landed: "The way we pitch to customers is different than how we'd talk to you guys. You're probably seeing some of that."

Suggested connections:

• Zen/Emily — for pitch feedback
• Tara (Flair) — for pitch feedback
• Hippo — potential investor fit
• Abhinav/Lipsa (GC) — similar FDE model, worth comparing notes

---

Interesting Moments

Revenue model clarity — Thomas gave the clearest revenue breakdown yet: SaaS fee (5-10%) + implementation fee (rate card, discount to Palantir) + maintenance/licensing fee (~50-60%). This is more specific than any prior call. Worth refining and using going forward.

Michael's pitch framing observation — "The way we pitch this to customers is going to be different from how we pitch to VCs... you're probably seeing some of that." Sam agreed this was exactly the issue.

---

Raw Transcript

[See above — ~35 minutes, Feb 6 2026]